Allarity Therapeutics Inc
NASDAQ:ALLR
Allarity Therapeutics Inc
NASDAQ:ALLR
Price:
1.01
USD
-3.81%
Market Closed
Market Cap:
$16.2m
Income Statement
Earnings Waterfall
Allarity Therapeutics Inc
Allarity Therapeutics Inc
Income Statement
Allarity Therapeutics Inc
Allarity Therapeutics Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(27)
|
(24)
|
(29)
|
(29)
|
(17)
|
(20)
|
(16)
|
(15)
|
(17)
|
(18)
|
(17)
|
(15)
|
(18)
|
(26)
|
(27)
|
(17)
|
|
| Selling, General & Administrative |
(12)
|
(12)
|
(15)
|
(14)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(9)
|
(8)
|
(11)
|
(11)
|
(11)
|
(10)
|
|
| Research & Development |
(14)
|
(12)
|
(14)
|
(16)
|
(7)
|
(7)
|
(6)
|
(5)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(5)
|
(7)
|
(7)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
|
| Operating Income |
(27)
N/A
|
(24)
+10%
|
(29)
-20%
|
(29)
-2%
|
(17)
+43%
|
(20)
-17%
|
(16)
+21%
|
(15)
+1%
|
(17)
-11%
|
(18)
-3%
|
(17)
+4%
|
(15)
+11%
|
(18)
-16%
|
(26)
-48%
|
(27)
-3%
|
(17)
+37%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
1
|
14
|
14
|
12
|
16
|
4
|
5
|
6
|
5
|
5
|
5
|
6
|
2
|
2
|
2
|
2
|
|
| Non-Reccuring Items |
(0)
|
(14)
|
(14)
|
(14)
|
(18)
|
0
|
(4)
|
(4)
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
1
|
3
|
3
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(27)
N/A
|
(22)
+16%
|
(28)
-23%
|
(31)
-14%
|
(18)
+44%
|
(17)
+5%
|
(14)
+16%
|
(13)
+4%
|
(12)
+11%
|
(12)
-4%
|
(12)
+6%
|
(19)
-65%
|
(25)
-30%
|
(24)
+4%
|
(24)
-3%
|
(15)
+37%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(0)
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(27)
|
(21)
|
(26)
|
(30)
|
(16)
|
(16)
|
(14)
|
(13)
|
(12)
|
(12)
|
(12)
|
(19)
|
(25)
|
(23)
|
(24)
|
(15)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(27)
N/A
|
(23)
+14%
|
(29)
-28%
|
(35)
-18%
|
(21)
+39%
|
(20)
+7%
|
(23)
-17%
|
(22)
+5%
|
(20)
+6%
|
(21)
-3%
|
(13)
+39%
|
(19)
-51%
|
(25)
-30%
|
(24)
+5%
|
(25)
-3%
|
(15)
+38%
|
|
| EPS (Diluted) |
-133 240
N/A
|
-76 513.33
+43%
|
-98 113.33
-28%
|
-115 886.66
-18%
|
-70 170
+39%
|
-39 242
+44%
|
-1 232.63
+97%
|
-176.2
+86%
|
-205.18
-16%
|
-119.45
+42%
|
-25.68
+79%
|
-12.32
+52%
|
-5.8
+53%
|
-2.15
+63%
|
-1.58
+27%
|
-1.03
+35%
|
|
Switch to:
Switch to:
See Also
Discover More
